Sitemap Contact Privacy Statement Imprint


conect4children - Collaborative network for European clinical trials for children
 

Less than half of all authorised medicines commonly used in children have been properly tested in this group, and running clinical trials involving children is hard. The conect4children (c4c) project aims to create a sustainable, integrated pan-European collaborative paediatric network that will speed up and facilitate the running of high quality clinical trials in children while ensuring that the voices of young patients and their families are heard. It will build the capacity for conducting multinational paediatric clinical trials for all disease areas and all phases of the clinical drug development process. One focus of the project is to promote innovative trial designs that will support drug development for rare paediatric diseases and areas of high medical need. The project will also set up an education and training platform for future leaders in paediatric drug development. Ultimately, the paediatric clinical trials network will contribute to the development of better medicines for babies, children and young people.

German Network for Paediatric Trials (GermanNetPaeT)
The GermanNetPaeT was founded in 2018 as part of the Innovative Medicines Initiative 2 (IMI 2) conect4children (c4c). Aim of the GermanNetPaeT is to improve pharmacotherapy in paediatric patients regarding safety and efficacy by making clinical trials in children and adolescents more effective. Ultimate goal is to provide highly potent medicines for children and adolescents. Major prerequisite is an improved liaison between pharmaceutical industry and paediatric clinical study centres comprising all issues to conduct clinical trials. Particular interest is given on Harmonisation of Documents & Procedures, Ethics & Regulations, Pharmacovigilance, Training & Education, Applied Biometry and Patient & Parent Involvement. One key feature of the GermanNetPaeT is the Single Point of Contact (SPoC) located at the head office at the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart. Currently more than 20 paediatric clinical study centres at hospitals for paediatrics and adolescent medicine and child and adolescent psychiatry are part of the GermanNetPaeT. The Network of Coordinating Centers for Clinical Studies (KKSN) strongly supports the GermanNetPaeT initiative. On behalf of the German Society of Pediatrics and Adolescent Medicine (DGKJ) all expert associations and working groups represented by the convent for collaboration of experts are affiliated. This guarantees the integration of experts for all paediatric subspecialities. Patient and parent representatives are also actively involved.

German Hub Leader: Matthias Schwab, MD - Head of the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology